driven by the PitchBook Platform
Developer of small molecule product candidates designed to treat cancer. The company's small molecule product candidates target Toll-like receptor 8 (TLR8), enabling cancer patients to get improved treatment.
You’re viewing a free company profile from the PitchBook Platform. To explore VentiRx Pharmaceuticals’s full profile, request a free trial.
2 Former Executives
© 2018 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.